{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:10:05Z","timestamp":1744121405377,"version":"3.40.3"},"reference-count":61,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.medcli.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T05:17:32Z","timestamp":1347599852000},"page":"582-587","source":"Crossref","is-referenced-by-count":3,"title":["Utilidad de los alfa-bloqueantes en el tratamiento de distintos trastornos urol\u00f3gicos"],"prefix":"10.1016","volume":"139","author":[{"given":"Carlos","family":"Hern\u00e1ndez Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Brenes Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Moncada Iribarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2012.06.006_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1464-410X.1975.tb03947.x","article-title":"Adrenergic and cholinergic receptors in human prostate, prostatic capsule and bladder neck","volume":"47","author":"Caine","year":"1975","journal-title":"Br J Urol"},{"issue":"Suppl2","key":"10.1016\/j.medcli.2012.06.006_bib0010","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/sj.bjp.0706619","article-title":"\u03b11, \u03b12 and \u03b2-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0015","doi-asserted-by":"crossref","first-page":"1.289","DOI":"10.1038\/sj.bjp.0701731","article-title":"Quantification and distribution of \u03b11-adrenoceptor subtype mRNAs in human proximal urethra","volume":"123","author":"Nasu","year":"1998","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride or both in BPH","volume":"335","author":"Lepor","year":"1966","journal-title":"New Engl J Med"},{"key":"10.1016\/j.medcli.2012.06.006_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1464-410X.1978.tb06210.x","article-title":"A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction","volume":"50","author":"Caine","year":"1978","journal-title":"Br J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur Urol"},{"issue":"5 Suppl. 2","key":"10.1016\/j.medcli.2012.06.006_bib0035","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.5489\/cuaj.11185","article-title":"Systematic review of overactive bladder therapy in females","volume":"5","author":"Cardozo","year":"2011","journal-title":"Can Urol Assoc"},{"key":"10.1016\/j.medcli.2012.06.006_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.juro.2011.03.028","article-title":"Silodosin for men with chronic prostatitis\/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study","volume":"186","author":"Nickel","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0210-4806(04)73077-6","article-title":"Tratamiento con Doxazosina en 3.347 pacientes con s\u00edntomas del tracto urinario inferior. Efectos sobre su funci\u00f3n sexual. Estudio IMPROS","volume":"28","author":"Hern\u00e1ndez","year":"2004","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.medcli.2012.06.006_bib0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1442-2042.2011.02810.x","article-title":"Efficacy of selective a1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones","volume":"18","author":"Itoh","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0055","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1442-2042.2011.02850.x","article-title":"Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: A randomized controlled study in Japanese male patients","volume":"18","author":"Tsuzaka","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOU.0b013e3282f13bbf","article-title":"Translation of benign prostatic hyperplasia guidelines into clinical practice","volume":"18","author":"Gravas","year":"2008","journal-title":"Curr Op Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2004.07.016","article-title":"EAU 2004 Guidelines on assessment, therapy and follow-up of men with lower urinary tract symproms suggestive of benign prostatic obstruction (BPH guidelines)","volume":"46","author":"Madersbacher","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2010.12.087","article-title":"Urologist compliance with AUA best practice Guidelines for benign prostatic hyperplasia in medicare population","volume":"78","author":"Strope","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.medcli.2012.06.006_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta-analisis on the efficacy and tolerability of alfa 1 adrenoceptor antagonist in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction","volume":"36","author":"Djavan","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000020246","article-title":"Medical therapy for benign prostatic hyperplasia: a review of the literature","volume":"38","author":"Clifford","year":"2000","journal-title":"Eur Urol"},{"issue":"Suppl. 3","key":"10.1016\/j.medcli.2012.06.006_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-410X.2008.07497.x","article-title":"BPH progression: concept and key learning from MTOPS; ALTESS;COMBAT and ALF_ONE","volume":"101","author":"Roehrborn","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0090-4295(99)80191-5","article-title":"Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men","volume":"46","author":"Kirby","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.medcli.2012.06.006_bib0100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(98)00126-5","article-title":"for the Tamsulosin investigator group. Phase III multicenter placebo-controlled study of Tansulosinin benign prostatic hyperplasia","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.medcli.2012.06.006_bib0105","first-page":"181","article-title":"Alpha bockers for the treatment of benign prostatic hyperplasia","volume":"9","author":"Lepor","year":"2007","journal-title":"Reviews Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0026-895X(25)10243-5","article-title":"KMD-3213, a novel potent, \u03b11a adrenoreceptor-selective antagonist: characterization using recombinant human \u03b11-adrenoceptors and native tissues","volume":"48","author":"Shibata","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0115","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","article-title":"Rapid efficacy of the highly selective alpha 1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies","volume":"181","author":"Marks","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eururo.2010.10.046","article-title":"European Silodosin study group. Silodosin therapy for lower urinary tract symptoms in men with suspectec benign prostatic hyperplasia: Results of an international, randomized, double-blind, placebo-and active-controlled clinical trial performed in Europe","volume":"59","author":"Chapple","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.urology.2009.06.072","article-title":"Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: A 9-month open \u2013label extension study","volume":"74","author":"Marks","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.medcli.2012.06.006_bib0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.urology.2009.10.042","article-title":"Lack of pharmacodinamic interaction of silodosin, a highly selective alpha 1A-adrenoceptor antagonist with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men","volume":"75","author":"MacDiarmid","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.medcli.2012.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.juro.2008.11.127","article-title":"Evaluation and treatment of lower urinary tract symptoms in older men","volume":"181","author":"Abrams","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0140","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1742-1241.2007.01491.x","article-title":"A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting","volume":"61","author":"Rosenberg","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.medcli.2012.06.006_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4321\/S0004-06142005000200006","article-title":"Prevalencia de Vejiga Hiperactiva en Espa\u00f1a: estudio poblacional\u2019","volume":"58","author":"Castro","year":"2005","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005392-199907000-00035","article-title":"Urodynamic characterization of nonobstructed voiding dysfunction in symptomatic elderly men","volume":"162","author":"Ameda","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0155","unstructured":"Salinas J, Mart\u00edn C. Aclarando conceptos: la vejiga hiperactiva y su patofisiologia. En Verdejo C. Vejiga hiperactiva y personas mayores (monograf\u00edas en geriatr\u00eda), 2004;9\u201320."},{"key":"10.1016\/j.medcli.2012.06.006_bib0160","unstructured":"Conejero J. Fisiopatolog\u00eda y clasificaci\u00f3n de la incontinencia urinaria. En Jim\u00e9nez Cruz F. Incontinencia urinaria. Med Clin Monogr. 2003;4:4\u20138."},{"key":"10.1016\/j.medcli.2012.06.006_bib0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nau.20837","article-title":"Neural control of the lower urinary tract: peripheral and spinal mechanisms","volume":"29","author":"Birder","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.medcli.2012.06.006_bib0170","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00345-009-0446-5","article-title":"Basic mechanisms of urgency: roles and benefits of pharmacotherapy","volume":"27","author":"Michel","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0175","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2165\/00003495-200464150-00003","article-title":"Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations","volume":"64","author":"Hashim","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.medcli.2012.06.006_bib0180","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/nau.20892","article-title":"Overactive bladder. Is there a link to the metabolic syndrome in men?","volume":"29","author":"Kirby","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.medcli.2012.06.006_bib0185","first-page":"159","article-title":"Prevalence of urinary incontinence and hyperactive bladder in the Spanish population: results of the EPICC study","volume":"33","author":"Mart\u00ednez Agull\u00f3","year":"2009","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.medcli.2012.06.006_bib0190","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/01.ju.0000139986.08972.e3","article-title":"Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction","volume":"172","author":"Mirone","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0210-4806(07)73604-5","article-title":"Utilidad de los antagonistas de los receptores muscar\u00ednicos en el tratamiento de los varones con s\u00edntomas del tracto urinario inferior secundarios a HBP","volume":"31","author":"Kaplan","year":"2007","journal-title":"Actas Urol Esp"},{"issue":"5 Suppl. 2","key":"10.1016\/j.medcli.2012.06.006_bib0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5489\/cuaj.11186","article-title":"Systematic review of therapy for men with overactive bladder","volume":"5","author":"Chapple","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.medcli.2012.06.006_bib0205","unstructured":"NICE clinical guideline. The management of lower urinary tract symptoms in men National Institute for Health and Clinical Excellence, 2010."},{"key":"10.1016\/j.medcli.2012.06.006_bib0210","article-title":"Guidelines on the Treatment of non-neurogenic male LUTS","author":"Oelke","year":"2011","journal-title":"European Association of Urology (EAU)"},{"key":"10.1016\/j.medcli.2012.06.006_bib0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with LUTS suggestive of BPH: A systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0220","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1464-410X.2010.09359.x","article-title":"Efficacy and safety of tolterodine-ER in men with overactive bladder symptoms treated with alpha-blocker: effect of baseline PSA concentrstion","volume":"106","author":"Chapple","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparision of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0230","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4065\/83.9.1002","article-title":"Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study","volume":"83","author":"MacDiarmid","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.medcli.2012.06.006_bib0235","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.medcli.2012.06.006_bib0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1464-410X.2009.08369.x","article-title":"The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS","volume":"103","author":"Sexton","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0245","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/nau.10057","article-title":"Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy","volume":"21","author":"Machino","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.medcli.2012.06.006_bib0250","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"28","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2012.06.006_bib0255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"Chronic Prostatitis CollaborativeResearch Network, The Nacional Institutes of Health Chronic Prostatitis Symptom Index","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0260","first-page":"492","article-title":"Bacteriologic localization patterns in bacterial prostatitis and urethritis","volume":"5","author":"Meares","year":"1968","journal-title":"InvestUrol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0265","first-page":"38","article-title":"The pre and post massage test (PPMT): a simple screenfor prostatitis","volume":"3","author":"Nickel","year":"1997","journal-title":"Tech Urol"},{"key":"10.1016\/j.medcli.2012.06.006_bib0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.2010.1913","article-title":"Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis","volume":"305","author":"Anothaisintawee","year":"2011","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.medcli.2012.06.006_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2008.07496.x","article-title":"Role of alpha1-blockers in chronic prostatitis syndromes","volume":"101","author":"Nickel","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.ijir.3900622","article-title":"Epidemiology of erectile dysfunction: results of the \u00abCologne Male Survey\u00bb","volume":"12","author":"Braun","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.medcli.2012.06.006_bib0285","first-page":"637","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"EurUrol"},{"issue":"Suppl. 2","key":"10.1016\/j.medcli.2012.06.006_bib0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2006.06102.x","article-title":"Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology","volume":"97","author":"McVary","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2012.06.006_bib0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00003495-200868020-00005","article-title":"Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction: implications for sexual dysfunction","volume":"68","author":"Gur","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.medcli.2012.06.006_bib0300","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archfami.2.7.729","article-title":"A population-basedstudy of healthcare-seeking behave or for treatment of urinary symptoms: the Olmsted County Study of Urinary Symptoms and Health Status Among Men","volume":"2","author":"Jacobsen","year":"1993","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.medcli.2012.06.006_bib0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.medcli.2008.01.001","article-title":"Evaluaci\u00f3n de la calidad de vida de los pacientes con c\u00e1ncer de pr\u00f3stata localizado: validaci\u00f3n de la versi\u00f3n espa\u00f1ola del cuestionario EPIC","volume":"4","author":"Ferrer","year":"2009","journal-title":"Med Clin (Barc)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312006008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312006008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:29:43Z","timestamp":1744118983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775312006008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0025775312006008"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2012.06.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}